Table 1.

Baseline Sample Characteristics of the Various Demographics, Clinical Variables, and Primary, Secondary Outcome Measures

Variables	Groups		P Value
	Group-1 (M-ECT) (n = 30)	Group-2 (Clozapine) (n = 30)
Male:female (%)	60:40	57:43	.99
Age (in years)	34.47 ± 10.29	35.80 ± 10.36	.62
Education (in years)	11.77 ± 3.75	12.23 ± 3.48	.62
Age of onset (in years)	25.5 ± 9.58	22.67 ± 5.76	.17
Duration of illness (DOI) (in years)	9.6 ± 7.36	12.8 ± 7.98	.11
PANSS-P	35.65 ± 4.87	35.78 ± 5.20	.93
PANSS-N	36.96 ± 6.35	37.41 ± 6.63	.79
PANSS-G	70.69 ± 9.69	70.85 ± 10.02	.95
PANSS-T	143.31 ± 14.13	144.04 ± 17.85	.86
CGI-SCH-S	6.192 ± 0.49	6.185 ± 0.60	.96
MOCA	19.08 ± 2.36	19.22 ± 2.19	.81
GAF	24.85 ± 5.97	22.11 ± 8.22	.15
Regional cerebral blood perfusion (SPECT-CT brain)a
RLPFC	−0.108 ± 0.04	−0.118 ± 0.06	.47
LLPFC	−0.103 ± 0.05	−0.110 ± 0.06	.62
RMPFC	−0.053 ± 0.06	−0.06 ± 0.06	.47
LMPFC	−0.057 ± 0.06	−0.088 ± 0.15	.30
RLT	−0.062 ± 0.04	−0.047 ± 0.05	.22
LLT	−0.061 ± 0.05	−0.046 ± 0.06	.28
RMT	−0.030 ± 0.05	−0.022 ± 0.06	.52
LMT	−0.018 ± 0.04	−0.001 ± 0.05	.14
RSP	−0.019 ± 0.05	−0.020 ± 0.05	.92
LSP	−0.002 ± 0.05	−0.021 ± 0.05	.16
RIP	−0.064 ± 0.03	−0.067 ± 0.06	.80
LIP	−0.062 ± 0.05	−0.076 ± 0.06	.28

Data are in mean ± SD, Independent t-test/Fisher’s exact test.

^aValues of SPECT-CT brain reflect the difference of regional cerebral blood perfusion of patient from normal reference. RLPFC, right lateral prefrontal cortex; LLPFC, left lateral prefrontal cortex; RMPFC, right medial prefrontal cortex; LMPFC, left media prefrontal cortex; RLT, right lateral temporal; LLT, left lateral temporal; RMT, right medial temporal; LMT, left medial Temporal; RSP, right superior parietal; LSP, left superior parietal; RIP, right inferior parietal; LIP, left inferior parietal.